But some people, including those with type 2 diabetes, have insulin resistance, meaning their cells struggle to absorb glucose even as their pancreas releases more and more insulin
Women are more likely to have done so (68%)
in the case of semaglutide 2.4mg, glucose disorder (prediabetes or DT2), hypertension, dyslipidemia, sleep obstructive apnea, or cardiovascular disease
Many people also notice a stronger drop in appetite at first
We don't just treat symptoms
By potentially enhancing the bodys natural GLP-1 response, it could contribute to managing energy levels, improving satiety, and stabilizing overall wellness